Literature DB >> 19160125

MicroRNAs in the ontogeny of leukemias and lymphomas.

Muller Fabbri1, Carlo M Croce, George A Calin.   

Abstract

MicroRNAs (miRNAs) are small non-coding RNAs with post-transcriptional regulatory functions. Their role in normal hematopoiesis is being elucidated by an increasing number of studies, revealing specific variations of the miRNome (defined as the full complement of miRNAs in a genome) during the commitment and development of the hematological stem cells in the different lineages. Aberrancies of the normal miRNome have also been well documented in almost all hematological malignancies, suggesting, in most cases, specific miRNA-signatures. Intriguingly, some of the miRNA-expression abnormalities described in leukemias and lymphomas can be interpreted on the basis of the miRNome variations during normal hematologic ontogeny, revealing their origin from the particular differentiation stage in which the hematopoietic differentiation has been 'frozen' in the malignancy.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19160125     DOI: 10.1080/10428190802535114

Source DB:  PubMed          Journal:  Leuk Lymphoma        ISSN: 1026-8022


  28 in total

Review 1.  Role of microRNAs in lymphoid biology and disease.

Authors:  Muller Fabbri; Carlo M Croce
Journal:  Curr Opin Hematol       Date:  2011-07       Impact factor: 3.284

2.  Environmental chemical exposures and human epigenetics.

Authors:  Lifang Hou; Xiao Zhang; Dong Wang; Andrea Baccarelli
Journal:  Int J Epidemiol       Date:  2011-12-13       Impact factor: 7.196

Review 3.  [Pathobiology of the microRNA system].

Authors:  K Hussein
Journal:  Pathologe       Date:  2012-02       Impact factor: 1.011

Review 4.  Environmental chemicals and microRNAs.

Authors:  Lifang Hou; Dong Wang; Andrea Baccarelli
Journal:  Mutat Res       Date:  2011-05-14       Impact factor: 2.433

5.  A microenvironment-mediated c-Myc/miR-548m/HDAC6 amplification loop in non-Hodgkin B cell lymphomas.

Authors:  Tint Lwin; Xiaohong Zhao; Fengdong Cheng; Xinwei Zhang; Andy Huang; Bijal Shah; Yizhuo Zhang; Lynn C Moscinski; Yong Sung Choi; Alan P Kozikowski; James E Bradner; William S Dalton; Eduardo Sotomayor; Jianguo Tao
Journal:  J Clin Invest       Date:  2013-11       Impact factor: 14.808

6.  Anticancer Role of PPARgamma Agonists in Hematological Malignancies Found in the Vasculature, Marrow, and Eyes.

Authors:  P J Simpson-Haidaris; S J Pollock; S Ramon; N Guo; C F Woeller; S E Feldon; R P Phipps
Journal:  PPAR Res       Date:  2010-02-28       Impact factor: 4.964

7.  HOXA9 regulates miR-155 in hematopoietic cells.

Authors:  Yu-Long Hu; Stephen Fong; Corey Largman; Wei-Fang Shen
Journal:  Nucleic Acids Res       Date:  2010-05-05       Impact factor: 16.971

Review 8.  Stem Cell Leukemia: how a TALented actor can go awry on the hematopoietic stage.

Authors:  N C Correia; M-L Arcangeli; F Pflumio; J T Barata
Journal:  Leukemia       Date:  2016-06-13       Impact factor: 11.528

Review 9.  Epigenetics, miRNAs, and human cancer: a new chapter in human gene regulation.

Authors:  Nicola Valeri; Ivan Vannini; Francesca Fanini; Federica Calore; Brett Adair; Muller Fabbri
Journal:  Mamm Genome       Date:  2009-08-22       Impact factor: 2.957

10.  miRGen 2.0: a database of microRNA genomic information and regulation.

Authors:  Panagiotis Alexiou; Thanasis Vergoulis; Martin Gleditzsch; George Prekas; Theodore Dalamagas; Molly Megraw; Ivo Grosse; Timos Sellis; Artemis G Hatzigeorgiou
Journal:  Nucleic Acids Res       Date:  2009-10-22       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.